About This Study
The goal of this study is to learn about a new cancer medicine called Sacituzumab Govitecan. This medicine is for patients whose endometrial cancer has returned. We want to find out if this medicine can help patients live longer and slow down or stop their cancer from growing. We will compare this medicine to regular chemotherapy treatments like doxorubicin or paclitaxel.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100 years old
- Female at Birth
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC